Duygu Demiroz Aslan, Mahmut Durmus, Neslihan Altunkaya Yagci

The effect of vitamin D deficiency in patients with trigeminal neuralgia: A case control study

An association between vitamin D deficiency and chronic pain has been suggested in several observations. The objective of this study was to determine whether there was an interrelation between patients with trigeminal neuralgia and vitamin D levels. This study included 45 patients. All patients were diagnosed with trigeminal neuralgia in the Department of Pain Management. Age, sex, diagnosis year, antiepileptic drug use and medication for trigeminal neuralgia (TN) treatment were obtained and recorded. Patients included in the study were grouped based on the Barrow Neurological Institute Pain lntensity Scale (BNI) as BNI 4 Group 2. Trigeminal neuralgia patient’s quantitative assessment of pain was performed under the supervision of a pain specialist who was blinded to the study. Demographic data were similar in each group. A patient in Group I and 13 patients in Group 2 had interventional pain therapies before blood samples were obtained. The mean level of vitamin D was found as 29.6 + 5.8 ng/ml in Group I and defined as insufficient. The mean level of vitamin D was 12.9 + 5.0 ng/ml in Group 2. The mean level of Vitamin D was significantly lower in patients with a BNI pain intensity value ≥4 (p < 0.001). lt is concluded that decreased serum vitamin D concentration was associated with trigeminal neuralgia. Although it is not easy to determine any causal correlation with a cross-sectional case control study, we concluded that vitamin D deficiency, as a risk factor for many acute and chronic diseases, was associated with pain severity in trigeminal neuralgia patients.

PDF

___

1. Chen J-F, Tu P-H, Lee S-T. Long-term follow-up of patients treated with percutaneous balloon compression for trigeminal neuralgia in Taiwan. World neurosurgery. 2011;76:586-91.
2. Kanpolat Y, Savas A, Bekar A, et al. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1600 patients. Neurosurgery. 2001;48:524-34.
3. Van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. PAIN®. 2014;155:654-62.
4. Katusic S, Beard CM, Bergstralth E, et al. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol. 1990;27:89-95.
5. Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain. 2002;18:4-13.
6. Montano N, Conforti G, Di Bonaventura R, et al. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015;11:289.
7. Hilton DA, Love S, Gradidge T, et al. Pathological findings associated with trigeminal neuralgia caused by vascular compression. Neurosurgery. 1994;35:299-303.
8. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124:2347-60.
9. Yoshida T, Stern PH. How vitamin D works on bone. Endocrinol Metab Clin North Am. 2012;41:557-69.
10. Garcion E, Wion-Barbot N, Montero-Menei CN , et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100-5.
11. Gezen-Ak D, Yılmazer S, Dursun E. Why vitamin D in Alzheimer's disease? The hypothesis. J Alzheimers Dis. 2014;40:257-69.
12. Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev. 2008;66:182-94.
13. Hyppönen E, Boucher BJ, Berry DJ, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort Diabetes. 2008;57:298-305.
14. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
15. Cook D, Guyatt G, Adachi J, et al. Development and validation of the miniosteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int. 1999;10:207-13.
16. Helde-Frankling M, Björkhem-Bergman L. Vitamin D in pain management. Int J Mol Sci. 2017;18:2170.
17. Zhang Y, Kong Q, Chen J, Li L, et al. International Classification of Headache Disorders 3rd edition beta-based field testing of vestibular migraine in China: Demographic,Clinical characteristics, audiometric findings and diagnosis statues. Cephalalgia. 2016;36:240-8.
18. Rogers CL, Shetter AG, Fiedler JA, et al.. Gamma knife radiosurgery for trigeminal neuralgia: the initial experience of The Barrow Neurological Institute. Int J Radiat Oncol Biol Phys. 2000;47:1013-9.
19. Osteoporosis and Metabolic bone dieases diagnosis and treatment guide. 2016.
20. Lewy F, Grant FC. Physiopathologic and pathoanatomic aspects of major trigeminal neuralgia. Archives Neurol Psychiatry. 1938;40:1126-34.
21. Knight G. Herpes simplex and trigeminal neuralgia. Proc R Soc Med 1954;47:788.
22. Jannetta P. Treatment of trigeminalneu-ralgia by micro-operative decompression. J Neurological Surgery. Philadelphia WB Saunders Co. 1982;6:589–603.
23. Fromm GH, Chattha AS, Terrence CF, et al. Role of inhibitory mechanisms in trigeminalneuralgia. Neurology. 1981;31:683.
24. Fidan F, Alkan BM, Tosun A. Pandemic era: Vitamin D deficiency and insufficiency. 2014.
25. Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005;10:94-111.
26. Ardawi M-S, Sibiany A, Bakhsh T, et al. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos Int. 2012;23:675-86.
27. Smolders J, Moen SM, Damoiseaux J, et al. Vitamin D in the healthy and inflamed central nervous system: access and function. J Neurol Sci. 2011;311:37-43.
28. Sandberg L, Biström M, Salzer J, et al. Vitamin D and axonal injury in multiple sclerosis. Mult Scler. 2016;22:1027-31.
29. Yong WC, Sanguankeo A, Upala S. Effect of vitamin D supplementation in chronic widespread pain: a systematic review and meta-analysis. Clin Rheumatol. 2017;36:2825-33.
30. Sismanlar T, Aslan AT, Gulbahar O, et al. The effect of vitamin D on lower respiratory tract infections in children. Turk Pediatri Ars. 2016;51:94.
31. Abdollahzadeh R, Fard MS, Rahmani F, et al. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study. J Neurol Sci. 2016;367:148-51.
32. da Costa DSM, Hygino J, Ferreira TB, et al. Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients. J Neuroimmunol. 2016;299:8-18.
33. Marie N, Summerday A, Sherrill J. Vitamin D and Multiple Sclerosis: Review of a Possible Association. J Pharm Pract. 2013;25:75.
34. Dörr J, Döring A, Paul F. Can we prevent or treat multiple sclerosis by individualised vitamin D supply? EPMA J 2013;4:4.
35. Wergeland S, Torkildsen Ø, Myhr K-M, et al. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. Plos one. 2011;6:26262.
36. Wang Y, Chiang Y-H, Su T-P, et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology. 2000;39:873-80.
37. Riaz S, Malcangio M, Miller M, et al. A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia. 1999;42:1308-13.
38. Yildiz EP, Poyrazoglu Ş, Bektas G, et al. Potential risk factors for vitamin D levels in medium-and long-term use of antiepileptic drugs in childhood. Acta Neurol Belg. 2017;11:447-53.